Therapeutic Ultrasound and Local Anesthetic Injection in the treatment of women with Chronic Pelvic Pain secondary to Myofascial Abdominal Syndrome: randomized clinical trial

Faculdade de Medicina de Ribeirão Preto - FMRP-USP0 个研究点开始时间: 2018年7月18日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Women older than eighteen years and not menopausal with clinical diagnosis of abdominal myofascial syndrome with presence of only one active trigger point and pain above four point four (moderate pain) in the visual analogue scale (VAS) and without previous treatments.

•Pregnant women with hip prosthesis, neoplasias in the abdomino-pelvic region, with severe osteoporosis, copper IUDs, abdominal varicose veins, cognitive deficits that make the questionnaires difficult to comprehend, women with anticoagulation or hemorrhagic disorders, local or systemic infections, allergy to anesthetics, acute muscle trauma, extreme fear of needles, history of complaints of chronic musculoskeletal pain such as fibromyalgia, chronic fatigue or diabetes. Also included in the exclusion criteria are those who use chronic painkillers, anti inflammatories, and tricyclic antidepressants who have used aspirin within three days prior to injection, all patients with suspected interstitial cystitis, bowel syndrome irritable or other disease that justifies or contributes to CPP, will also be part of the criteria for exclusion of endometrioma or hernia evidenced by ultrasound of the abdominal wall, abdominal wall infections and women who are missing after the start of treatment.

发起方

Faculdade de Medicina de Ribeirão Preto - FMRP-USP